Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Discovery Grants Program - Individual

McGill University

$26,000.00

Study of the Vesicular Monoamine Transporter: Role and Function

FY 2015-16

Summary
Synthesized in only a few restricted nuclei in the brain, the three monoamines (MA) neurotransmitters, dopamine, serotonin and noradrenalin, are altogether the major regulators of almost all superior brain functions. The importance of MA neurotransmission is highlighted by their direct implication in functions as diversed as sleep processes, executive functions, learning and memory, pain, anxiety, arousal, motivation, locomotor control, reward, etc etc.... At the present time, more than 80% of psychotropic or recreative drugs that are used, are directly targeting receptors or transporters specific for these three monoamines. Only one vesicular transporter, the vesicular monoamine transporter (VMAT2) is accumulating MA in their specific vesicles, that will be further released from the nerve terminals, to activates the various receptors. Therefore, the VMAT2 controls MA concentration in the terminals, and the intensity of the monoamine release at the synapse. However, because the same VMAT2 is present in all MA terminals, dopamine, serotonin or noradrenalin, it is not possible to study each system separately, and therefore to be able to understand how the control of transmitter fluxes, and the balance between these three MA systems, is possibly involved to regulates brain functions. We have now produced a genetic mouse model allowing, for the first time, the conditional suppression of VMAT2 in specific neuronal subsets, or at specific times during development and adulthood. This model will now allow us, within the next years, to unravel these very important questions, and to have eventually a better understanding of the respective role and circuits of these three intermingled and essential neurotranmitter systems.
Program
Discovery Grants Program - Individual
Location
Quebec, Canada
Recipient Type
Academia
Type
Grant
Source
NSERC's Awards Data

As published

Application id
385732-2012
Name nom
Giros, Bruno
Department département
Psychiatry
Organization id
61
Institution établissement
McGill University
Province en
Québec
Province fr
Québec
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2015
Competition year année de concours
2012
Award amount
26000
Program id
RGPIN
Program name en
Discovery Grants Program - Individual
Program name fr
Programme de subventions à la découverte - individuelles
Group en
Discovery grants programs
Group fr
Programmes de subventions à la découverte
Committee code
1501
Committee name en
Genes, Cells and Molecules
Committee name fr
Gènes, cellules et molécules
Area of application code
1101
Area of application group en
Health, education and social services
Area of application group fr
Santé publique, éducation et services sociaux
Area of application en
Human health (including medically-related psychological research)
Area of application fr
Santé publique (y compris recherche psychologique liée à la médecine)
Research subject code
6404
Research subject group en
Life sciences research related to human health and disease
Research subject group fr
Sciences de la vie liées à la santé publique et aux maladies humaines
Research subject en
Pharmacology
Research subject fr
Pharmacologie
Partie
4
Nb partie
5
Application title
Study of the Vesicular Monoamine Transporter: Role and Function
Keyword
NSERC
Application summary
Synthesized in only a few restricted nuclei in the brain, the three monoamines (MA) neurotransmitters, dopamine, serotonin and noradrenalin, are altogether the major regulators of almost all superior brain functions. The importance of MA neurotransmission is highlighted by their direct implication in functions as diversed as sleep processes, executive functions, learning and memory, pain, anxiety, arousal, motivation, locomotor control, reward, etc etc.... At the present time, more than 80% of psychotropic or recreative drugs that are used, are directly targeting receptors or transporters specific for these three monoamines. Only one vesicular transporter, the vesicular monoamine transporter (VMAT2) is accumulating MA in their specific vesicles, that will be further released from the nerve terminals, to activates the various receptors. Therefore, the VMAT2 controls MA concentration in the terminals, and the intensity of the monoamine release at the synapse. However, because the same VMAT2 is present in all MA terminals, dopamine, serotonin or noradrenalin, it is not possible to study each system separately, and therefore to be able to understand how the control of transmitter fluxes, and the balance between these three MA systems, is possibly involved to regulates brain functions. We have now produced a genetic mouse model allowing, for the first time, the conditional suppression of VMAT2 in specific neuronal subsets, or at specific times during development and adulthood. This model will now allow us, within the next years, to unravel these very important questions, and to have eventually a better understanding of the respective role and circuits of these three intermingled and essential neurotranmitter systems.